DE69810601D1 - Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung - Google Patents
Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichungInfo
- Publication number
- DE69810601D1 DE69810601D1 DE69810601T DE69810601T DE69810601D1 DE 69810601 D1 DE69810601 D1 DE 69810601D1 DE 69810601 T DE69810601 T DE 69810601T DE 69810601 T DE69810601 T DE 69810601T DE 69810601 D1 DE69810601 D1 DE 69810601D1
- Authority
- DE
- Germany
- Prior art keywords
- oral administration
- compositions containing
- solid compositions
- magnesium citrate
- carnitine magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000198A IT1291134B1 (it) | 1997-04-08 | 1997-04-08 | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
PCT/IT1998/000058 WO1998044918A1 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69810601D1 true DE69810601D1 (de) | 2003-02-13 |
DE69810601T2 DE69810601T2 (de) | 2003-08-07 |
Family
ID=11404949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69810601T Expired - Lifetime DE69810601T2 (de) | 1997-04-08 | 1998-03-19 | Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung |
Country Status (15)
Country | Link |
---|---|
US (1) | US6337349B2 (de) |
EP (1) | EP0973515B1 (de) |
JP (1) | JP4047936B2 (de) |
KR (1) | KR100517680B1 (de) |
AT (1) | ATE230595T1 (de) |
AU (1) | AU739522B2 (de) |
BR (1) | BR9808494B1 (de) |
CA (1) | CA2285552C (de) |
DE (1) | DE69810601T2 (de) |
DK (1) | DK0973515T3 (de) |
ES (1) | ES2190069T3 (de) |
HK (1) | HK1025242A1 (de) |
IT (1) | IT1291134B1 (de) |
NZ (1) | NZ500532A (de) |
WO (1) | WO1998044918A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002017735A2 (de) * | 2000-08-29 | 2002-03-07 | Lonza Ag | Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat |
ITRM20020055A1 (it) * | 2002-02-04 | 2003-08-04 | Aldo Fassi | Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
WO2007043339A1 (en) * | 2005-09-30 | 2007-04-19 | Showa Denko K.K. | Carnitine derivative, salt thereof, external skin preparation and cosmetic material |
CN101209975B (zh) | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
US8466187B2 (en) | 2007-09-18 | 2013-06-18 | Thermolife International, Llc | Amino acid compositions |
US10435356B1 (en) * | 2007-09-18 | 2019-10-08 | Thermolife International, Llc | Amino acid compositions |
US10646508B1 (en) | 2007-09-18 | 2020-05-12 | Thermolife International, Llc | Method of safely administering nitrate dietary supplements and compositions |
US10426792B1 (en) * | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid compositions |
US10426750B1 (en) * | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid supplement formulations |
JP2011524415A (ja) * | 2008-06-16 | 2011-09-01 | サイアン ラボラトリーズ,エルエルシー | L−カルニチンフィチン酸塩及びアルカノイル−l−カルニチンフィチン酸塩と、その製造方法 |
WO2012142474A2 (en) | 2011-04-13 | 2012-10-18 | Thermolife International, Llc | N-acetyl beta alanine methods of use |
CN105777534B (zh) * | 2014-12-24 | 2018-07-06 | 辽宁科硕营养科技有限公司 | 柠檬酸钙盐及其制备方法与用途 |
US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
FR2529545B1 (fr) * | 1982-07-02 | 1985-05-31 | Sanofi Sa | Nouveaux sels de carnitine ainsi que leur procede de preparation |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
CA2018137C (en) * | 1989-06-14 | 2000-01-11 | Thomas Scholl | L-carnitine magnesium citrate |
US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
IT1261688B (it) * | 1993-05-28 | 1996-05-29 | Avantgarde Spa | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
EP0681839A3 (de) * | 1994-05-12 | 1997-11-12 | Hirohiko Kuratsune | Acylcarnitin-enthaltende pharmazeutische Zusammensetzung |
-
1997
- 1997-04-08 IT IT97RM000198A patent/IT1291134B1/it active IP Right Grant
-
1998
- 1998-03-19 ES ES98912693T patent/ES2190069T3/es not_active Expired - Lifetime
- 1998-03-19 NZ NZ500532A patent/NZ500532A/xx unknown
- 1998-03-19 AU AU67453/98A patent/AU739522B2/en not_active Ceased
- 1998-03-19 CA CA002285552A patent/CA2285552C/en not_active Expired - Fee Related
- 1998-03-19 US US09/381,730 patent/US6337349B2/en not_active Expired - Fee Related
- 1998-03-19 DK DK98912693T patent/DK0973515T3/da active
- 1998-03-19 BR BRPI9808494-1A patent/BR9808494B1/pt not_active IP Right Cessation
- 1998-03-19 KR KR10-1999-7008940A patent/KR100517680B1/ko not_active IP Right Cessation
- 1998-03-19 WO PCT/IT1998/000058 patent/WO1998044918A1/en active IP Right Grant
- 1998-03-19 DE DE69810601T patent/DE69810601T2/de not_active Expired - Lifetime
- 1998-03-19 EP EP98912693A patent/EP0973515B1/de not_active Expired - Lifetime
- 1998-03-19 AT AT98912693T patent/ATE230595T1/de not_active IP Right Cessation
- 1998-03-19 JP JP54256498A patent/JP4047936B2/ja not_active Expired - Fee Related
-
2000
- 2000-04-20 HK HK00102416A patent/HK1025242A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010005864A (ko) | 2001-01-15 |
AU739522B2 (en) | 2001-10-11 |
BR9808494A (pt) | 2000-05-23 |
ES2190069T3 (es) | 2003-07-16 |
EP0973515B1 (de) | 2003-01-08 |
ITRM970198A1 (it) | 1998-10-08 |
DK0973515T3 (da) | 2003-05-05 |
CA2285552C (en) | 2008-06-03 |
KR100517680B1 (ko) | 2005-09-29 |
CA2285552A1 (en) | 1998-10-15 |
WO1998044918A1 (en) | 1998-10-15 |
JP2001519804A (ja) | 2001-10-23 |
EP0973515A1 (de) | 2000-01-26 |
BR9808494B1 (pt) | 2009-05-05 |
HK1025242A1 (en) | 2000-11-10 |
JP4047936B2 (ja) | 2008-02-13 |
IT1291134B1 (it) | 1998-12-29 |
US6337349B2 (en) | 2002-01-08 |
AU6745398A (en) | 1998-10-30 |
ATE230595T1 (de) | 2003-01-15 |
US20010027214A1 (en) | 2001-10-04 |
DE69810601T2 (de) | 2003-08-07 |
NZ500532A (en) | 2001-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69810601D1 (de) | Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung | |
HK1025559A1 (en) | Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate | |
PT971879E (pt) | Composicoes solidas adequadas para administracao oral compreendendo l-carnitino e alcanoil.l.carnitino tartarato de magnesio | |
PL335937A1 (en) | Solid compositions suitable for oral administration and containing non-hygroscopic 2-aminoethanosulphonic salts of l-carnitin and alkanoyl-l-carnitin | |
HK1025562A1 (en) | Solid compositions suitable for oral administration comprising l-carnitine choline tartrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |